Source comparison
What evidence supports cyclical versus continuous BPC-157 use?
BPC-157 does not need to be cycled in the traditional sense — most protocols are self-limiting courses of 4–8 weeks rather than continuous use, running for the duration that addresses the injury or condition and then stopping. There is no known tolerance build
This comparison does not assign a generated winner or score.
- BPC-157 does not need to be cycled in the traditional sense — most protocols are self-limiting courses of 4–8 weeks rather than continuous use, running for the duration that addresses the injury or condition and then stopping. There is no known tolerance buildup, and side effects don’t increase with longer use. Repeat courses can be run if a new injury occurs or symptoms recur after the initial course.